Diltiazem Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00343 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 21 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obsolete susceptibility to ischemic stroke | KG + DL |
| 2 | brain stem infarction | KG + DL |
| 3 | obsolete bundle branch block | KG + DL |
| 4 | cerebrovascular disorder | KG + DL |
| 5 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 6 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 7 | malignant renovascular hypertension | KG + DL |
| 8 | malignant hypertensive renal disease | KG + DL |
| 9 | ABri amyloidosis | KG + DL |
| 10 | Braddock syndrome | KG + DL |
| 11 | cerebral artery occlusion | KG + DL |
| 12 | cerebral infarction | KG + DL |
| 13 | intracerebral hemorrhage | KG + DL |
| 14 | periodic paralysis with transient compartment-like syndrome | KG + DL |
| 15 | MRI defined brain infarct | KG + DL |
| 16 | cerebral arterial disease | KG + DL |
| 17 | chronic pulmonary heart disease | KG + DL |
| 18 | stroke disorder | KG + DL |
| 19 | arrhythmogenic right ventricular cardiomyopathy | KG + DL |
| 20 | spinal cord ischemia | KG + DL |
| 21 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.